consistent efficacy of inebilizumab across newly presenting and previously treated nmosd cases
Published 2 years ago • 58 plays • Length 1:48
Download video MP4
Download video MP3
Similar videos
-
8:16
distinctive attributes and efficacy of inebilizumab in nmosd
-
1:56
inebilizumab in aqp4 nmosd patients with history of immunosuppression treatment: n-momentum study
-
1:39
recent progress and future needs in nmosd treatment
-
2:50
chronic cognitive impairment improved after eculizumab initiation in cases of nmosd
-
2:44
updates on n-momentum: inebilizumab versus placebo in patients with nmosd
-
1:51
selecting treatment options for nmosd
-
20:19
nmosd multidisciplinary approach webinar, 25 june 2021 - dr. suzan ibrahim noori
-
2:27
key considerations for clinicians treating nmosd
-
4:49
comorbidities in ms and nmosd
-
2:00
inebilizumab: proposed mechanism of action for treating nmosd
-
4:39
revising the neuromyelitis optica criteria
-
5:44
diagnostic criteria and treatment updates for nmosd
-
4:41
bruce cree, md, phd, mas: inebilizumab for nmosd treatment
-
4:26
bruce cree, md, phd, mas: the nmosd landscape after the inebilizumab approval
-
7:45
neuromyelitis optica: new treatments and areas of development
-
1:28
current and emerging therapeutics for nmosd
-
3:10
bruce cree, md, phd, mas: inebilizumab in neuromyelitis optica spectrum disorder
-
9:25
mayo clinic research improves diagnosis and potential treatment of neuromyelitis optica
Clip.africa.com - Privacy-policy